Research ExplorerPublicationsAdjuvant chemotherapy with fluorouracil plus folinic acid vs...

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Standard

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. / Neoptolemos, John P; Stocken, Deborah D; Bassi, Claudio; Ghaneh, Paula; Cunningham, David; Goldstein, David; Padbury, Robert; Moore, Malcolm J; Gallinger, Steven; Mariette, Christophe; Wente, Moritz N; Izbicki, Jakob R.; Friess, Helmut; Lerch, Markus M; Dervenis, Christos; Oláh, Attila; Butturini, Giovanni; Doi, Ryuichiro; Lind, Pehr A; Smith, David; Valle, Juan W; Palmer, Daniel H; Buckels, John A; Thompson, Joyce; McKay, Colin J; Rawcliffe, Charlotte L; Büchler, Markus W.

In: JAMA-J AM MED ASSOC, Vol. 304, No. 10, 10, 2010, p. 1073-1081.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Neoptolemos, JP, Stocken, DD, Bassi, C, Ghaneh, P, Cunningham, D, Goldstein, D, Padbury, R, Moore, MJ, Gallinger, S, Mariette, C, Wente, MN, Izbicki, JR, Friess, H, Lerch, MM, Dervenis, C, Oláh, A, Butturini, G, Doi, R, Lind, PA, Smith, D, Valle, JW, Palmer, DH, Buckels, JA, Thompson, J, McKay, CJ, Rawcliffe, CL & Büchler, MW 2010, 'Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.', JAMA-J AM MED ASSOC, vol. 304, no. 10, 10, pp. 1073-1081. <http://www.ncbi.nlm.nih.gov/pubmed/20823433?dopt=Citation>

APA

Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., Wente, M. N., Izbicki, J. R., Friess, H., Lerch, M. M., Dervenis, C., Oláh, A., Butturini, G., Doi, R., Lind, P. A., ... Büchler, M. W. (2010). Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA-J AM MED ASSOC, 304(10), 1073-1081. [10]. http://www.ncbi.nlm.nih.gov/pubmed/20823433?dopt=Citation

Vancouver

Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA-J AM MED ASSOC. 2010;304(10):1073-1081. 10.

Bibtex

@article{c20b11d9c13f43baa5d43d92d301f936,
title = "Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.",
abstract = "Adjuvant fluorouracil has been shown to be of benefit for patients with resected pancreatic cancer. Gemcitabine is known to be the most effective agent in advanced disease as well as an effective agent in patients with resected pancreatic cancer.",
author = "Neoptolemos, {John P} and Stocken, {Deborah D} and Claudio Bassi and Paula Ghaneh and David Cunningham and David Goldstein and Robert Padbury and Moore, {Malcolm J} and Steven Gallinger and Christophe Mariette and Wente, {Moritz N} and Izbicki, {Jakob R.} and Helmut Friess and Lerch, {Markus M} and Christos Dervenis and Attila Ol{\'a}h and Giovanni Butturini and Ryuichiro Doi and Lind, {Pehr A} and David Smith and Valle, {Juan W} and Palmer, {Daniel H} and Buckels, {John A} and Joyce Thompson and McKay, {Colin J} and Rawcliffe, {Charlotte L} and B{\"u}chler, {Markus W}",
year = "2010",
language = "Deutsch",
volume = "304",
pages = "1073--1081",
journal = "JAMA-J AM MED ASSOC",
issn = "0098-7484",
publisher = "American Medical Association",
number = "10",

}

RIS

TY - JOUR

T1 - Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

AU - Neoptolemos, John P

AU - Stocken, Deborah D

AU - Bassi, Claudio

AU - Ghaneh, Paula

AU - Cunningham, David

AU - Goldstein, David

AU - Padbury, Robert

AU - Moore, Malcolm J

AU - Gallinger, Steven

AU - Mariette, Christophe

AU - Wente, Moritz N

AU - Izbicki, Jakob R.

AU - Friess, Helmut

AU - Lerch, Markus M

AU - Dervenis, Christos

AU - Oláh, Attila

AU - Butturini, Giovanni

AU - Doi, Ryuichiro

AU - Lind, Pehr A

AU - Smith, David

AU - Valle, Juan W

AU - Palmer, Daniel H

AU - Buckels, John A

AU - Thompson, Joyce

AU - McKay, Colin J

AU - Rawcliffe, Charlotte L

AU - Büchler, Markus W

PY - 2010

Y1 - 2010

N2 - Adjuvant fluorouracil has been shown to be of benefit for patients with resected pancreatic cancer. Gemcitabine is known to be the most effective agent in advanced disease as well as an effective agent in patients with resected pancreatic cancer.

AB - Adjuvant fluorouracil has been shown to be of benefit for patients with resected pancreatic cancer. Gemcitabine is known to be the most effective agent in advanced disease as well as an effective agent in patients with resected pancreatic cancer.

M3 - SCORING: Zeitschriftenaufsatz

VL - 304

SP - 1073

EP - 1081

JO - JAMA-J AM MED ASSOC

JF - JAMA-J AM MED ASSOC

SN - 0098-7484

IS - 10

M1 - 10

ER -